ZIONEXA US CORPORATION

Lobbying Spend

—

Filings

Firms Hired

Active Period

2018–2020

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2020	—	4	1
2019	—	4	1
2018	—	5	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
BOSE PUBLIC AFFAIRS GROUP	—	13

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	12
SENATE	5

Most frequently reported lobbying issues

Issue Code	Description	Reports
Insurance	Insurance	12
Health Issues	Health Issues	1

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 6948115th Congress

Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2018

2018 · fourth_quarter · Firm: BOSE PUBLIC AFFAIRS GROUP

Cited source text and reported amounts

HR 6948 Medicare Diagnostic radiopharmaceutical payment equity act of 2018

Client expense: — · Firm income: $10,000

Matched citations: HR 6948

ZIONEXA US CORPORATION — Lobbying Disclosure | Poliscope